Costly Blood Clots More Common than Expected Among Cancer Patients (DukeHealth.org)
Sept. 19, 2011
An analysis of more than 30,000 cancer patients has shown that blood clots are a more common complication than doctors may realize, causing additional hospitalizations and driving up the cost of care, according to a study led by a Duke Cancer Institute researcher.
Elusive Gene Mutations Found for Malignant Brain Tumor (DukeHealth.org)
Aug. 4, 2011
A discovery by scientists at Duke University Medical Center and Johns Hopkins University could increase the chances for an effective combination of drug therapy to treat the second most common type of brain tumor.
Duke Team Finds New Clues to How Cancer Spreads (DukeHealth.org)
June 27, 2011
Cancer cells circulating in the blood carry newly identified proteins that could be screened to improve prognostic tests and suggest targets for therapies, report scientists at the Duke Cancer Institute.
Altered Cell Metabolism Has Role in Brain Tumor Development (DukeHealth.org)
Jan. 31, 2011
Scientists at Duke Cancer Institute have discovered that genetic mutations found in brain tumors can alter tumor metabolism. This work could help lead to new designs for anti-cancer drugs based on the unique properties of these tumors.